vascular-disrupting - Globe Thesis

Keyword [vascular-disrupting] Result: 1 - 17 \| Page: 1 of 1
1.	Numerical Study Of Tumor Hemodynamics For Vascular-targeted Therapy
2.	Study Of Combretastatin A4Phosphate Analogues Antineoplasm In Vitro And In Vivo
3.	Screening And Pharmacodynamic Evaluation Of Tumor Vas-cular Disrupting Agent From Ocean
4.	The Drugability Study Of MDS-11P, A Combretastatin Prodrug Analogue, On Anticancer Effects With Vascular Disrupting Activity
5.	Synthesis And In Vitro Antitumor Activities Of Natural Flavones, Flavans, Homoisoflavanone And Their Related Compounds
6.	Design, Synthesis And Anti-tumor Activities Of Novel 3-Aryl Flavone Acetic Acid Derivatives
7.	Assessment The Early Changes Of Nude Mice Huh7 Hepatocellular Carcinoma Xenografts Response To Vascular Disrupting Agent A64 With Contrast Enhanced Ultrasound
8.	Application Of A Poly(L-glutamic Acid)-Combretastatin A4 Conjugates(PLG-CA4) Nanoparticles For The Treatment Of Colon Cancer
9.	Synthesis And Anti-tumor Activities Of Novel Flavone Acetic Acid Andbenzofur An Derivatives
10.	Study Of Combretastatin A4 Polymer Conjugate Nanoparticles In Combination With Sorafenib For The Inhibition Of H22 Hepatoma
11.	Co-administration Of JQ1 And Anti-CD47 Antibody Or Combretastatin A4 Nanoparticles In The Therapy Of Lymphoma And The Associated Mechanism
12.	A Novel Class Of Tubulin-binding Tumor-vascular Disrupting Agents (Tumor-VDAs):Synthesis,Optimization,and Biological Evaluation Of N-(4-Quinazoline)-3,4-dihydroquinoxaline-2-ones
13.	Design,Synthesis And Anti-cancer Activity Of Combretastatin Analogues
14.	Experimental Study On The Sequential Dual-targeting Treatment Of Breast Cancer With Nanodrug Combined With Vascular-disrupting Agent
15.	Discovery and development of unique small molecule chromene based ligands and combretastatin analogs as potential second generation vascular disrupting agents towards cancer chemotherapy
16.	Anti-tumor Strategies Aimed At Tumor Vasculature
17.	Synergistic Enhancement Of Erlotinib In The Treatment Of Pancreatic Cancer By CA4(combretastatin A4) Nanoparticles
<<First <Prev Next> Last>> Jump to